Stock listing
Dusseldorf:UP0 Ultragenyx Pharmaceutical Inc. Aktie
German listing (Dusseldorf) of Ultragenyx Pharmaceutical Inc. · home listing NASDAQ:RARE
Follow Ultragenyx Pharmaceutical Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:RARE
$16.48 USD -1.25 (-7.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RARE
- Day range
- $16.43 – $17.35 USDNov 20, 2026
- Volume
- 3.01M sharesNov 20, 2026
- Market cap
- $1.68B USDAt the close on Nov 20, 2026 · price × 101.9M shares outstanding
- 52-week range
- $12.73 – $39.89 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $75.58M USDMedian day 3.88M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RARE · Home | $16.48 USD | -1.25 (-7.1%) | 3,009,629 | $16.94 | $17.35 | $16.43 | $17.73 | Close on Nov 20, 2026 |
| LSE:0LIF | $16.55 USD | -0.80 (-4.6%) | 2,019 | $16.69 | $17.25 | $16.50 | $17.35 | Close on Nov 20, 2026 |
| Frankfurt:UP0 | €15.49 EUR | -0.525 (-3.3%) | — | €15.49 | €15.49 | €15.49 | €16.01 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RARE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $16.48 | -1.25 | -7.1% | $16.94 | $17.35 | $16.43 | 3,009,629 | |
| $17.73 | +1.03 | +6.2% | $16.76 | $17.77 | $16.69 | 5,163,344 | |
| $16.70 | +0.80 | +5.0% | $15.94 | $16.74 | $15.65 | 5,591,896 | |
| $15.90 | -0.18 | -1.1% | $15.88 | $16.39 | $15.79 | 5,252,620 | |
| $16.08 | -0.19 | -1.2% | $16.30 | $16.33 | $15.85 | 1,679,323 | |
| $16.27 | -0.43 | -2.6% | $16.48 | $16.62 | $16.16 | 3,617,062 | |
| $16.70 | +0.56 | +3.5% | $16.30 | $16.78 | $16.17 | 2,673,622 | |
| $16.14 | -0.27 | -1.6% | $16.17 | $16.35 | $15.46 | 5,464,470 | |
| $16.41 | +0.98 | +6.4% | $15.75 | $16.51 | $15.32 | 2,668,986 | |
| $15.43 | -0.14 | -0.9% | $15.68 | $15.97 | $15.12 | 4,049,091 | |
| $15.57 | -1.59 | -9.3% | $17.07 | $17.12 | $15.49 | 5,383,215 | |
| $17.16 | +0.53 | +3.2% | $17.04 | $17.67 | $16.23 | 7,330,565 | |
| $16.63 | +0.33 | +2.0% | $16.52 | $16.99 | $16.39 | 3,671,217 | |
| $16.30 | +0.20 | +1.2% | $16.29 | $16.44 | $15.85 | 4,840,905 | |
| $16.10 | -0.68 | -4.1% | $16.64 | $16.93 | $15.92 | 2,333,527 | |
| $16.78 | -0.42 | -2.4% | $17.26 | $17.63 | $16.71 | 2,801,874 | |
| $17.20 | +0.45 | +2.7% | $16.73 | $17.35 | $16.47 | 2,319,744 | |
| $16.75 | +0.67 | +4.2% | $16.05 | $16.96 | $15.88 | 4,943,979 | |
| $16.08 | +0.43 | +2.7% | $15.77 | $16.22 | $15.60 | 3,022,884 | |
| $15.65 | -0.30 | -1.9% | $15.92 | $15.94 | $15.49 | 1,789,100 | |
| $15.95 | +0.03 | +0.2% | $15.78 | $16.25 | $15.60 | 2,374,100 | |
| $15.92 | -0.10 | -0.6% | $16.02 | $16.31 | $15.79 | 2,825,000 | |
| $16.02 | +0.95 | +6.3% | $15.01 | $16.27 | $14.99 | 3,546,000 | |
| $15.07 | +0.53 | +3.6% | $14.67 | $15.08 | $14.54 | 2,984,400 | |
| $14.54 | -0.63 | -4.2% | $15.11 | $15.21 | $14.44 | 2,924,000 | |
| $15.17 | +0.27 | +1.8% | $14.87 | $15.37 | $14.79 | 3,332,000 | |
| $14.90 | -0.02 | -0.1% | $14.93 | $15.18 | $14.67 | 2,953,000 | |
| $14.92 | -0.38 | -2.5% | $15.27 | $15.39 | $14.69 | 5,305,200 | |
| $15.30 | -0.18 | -1.2% | $15.42 | $15.49 | $15.10 | 2,898,600 | |
| $15.48 | +0.19 | +1.2% | $15.30 | $15.73 | $15.23 | 2,927,600 | |
| $15.29 | +0.40 | +2.7% | $14.79 | $15.52 | $14.43 | 5,396,500 | |
| $14.89 | +0.43 | +3.0% | $14.37 | $15.25 | $14.35 | 4,162,500 | |
| $14.46 | -0.04 | -0.3% | $14.60 | $14.70 | $14.08 | 3,892,000 | |
| $14.50 | -0.72 | -4.7% | $15.25 | $15.31 | $14.21 | 4,656,500 | |
| $15.22 | +0.47 | +3.2% | $14.90 | $15.28 | $14.67 | 3,880,500 | |
| $14.75 | -0.28 | -1.9% | $15.03 | $15.25 | $14.62 | 4,116,000 | |
| $15.03 | -0.29 | -1.9% | $15.48 | $15.53 | $14.86 | 4,421,200 | |
| $15.32 | +0.91 | +6.3% | $14.46 | $15.50 | $14.11 | 5,884,600 | |
| $14.41 | -0.09 | -0.6% | $14.33 | $14.47 | $14.11 | 4,939,900 | |
| $14.50 | -0.27 | -1.8% | $14.87 | $14.94 | $14.15 | 4,303,700 | |
| $14.77 | -0.11 | -0.7% | $14.73 | $14.87 | $14.55 | 3,488,700 | |
| $14.88 | -0.735 | -4.7% | $15.40 | $15.50 | $14.54 | 5,704,900 | |
| $15.62 | +0.965 | +6.6% | $14.78 | $16.12 | $14.48 | 8,134,200 | |
| $14.65 | +0.14 | +1.0% | $14.58 | $15.01 | $14.28 | 5,269,500 | |
| $14.51 | +0.01 | +0.1% | $14.79 | $15.07 | $14.07 | 13,328,100 | |
| $14.50 | +1.62 | +12.6% | $13.22 | $14.58 | $13.20 | 12,427,800 | |
| $12.88 | -0.19 | -1.5% | $13.07 | $13.22 | $12.73 | 5,031,200 | |
| $13.07 | -0.54 | -4.0% | $13.56 | $13.59 | $12.88 | 5,655,000 | |
| $13.61 | -0.69 | -4.8% | $14.44 | $14.44 | $13.60 | 5,929,200 | |
| $14.30 | -0.10 | -0.7% | $14.43 | $14.70 | $14.13 | 3,252,100 | |
| $14.40 | +0.09 | +0.6% | $14.25 | $14.44 | $13.95 | 3,659,800 | |
| $14.31 | -0.57 | -3.8% | $14.77 | $15.20 | $14.27 | 4,573,600 | |
| $14.88 | -0.42 | -2.7% | $15.10 | $15.25 | $14.63 | 5,926,500 | |
| $15.30 | +0.45 | +3.0% | $15.48 | $16.08 | $15.23 | 11,494,500 | |
| $14.85 | -11.68 | -44.0% | $14.00 | $15.00 | $13.81 | 27,159,700 | |
| $26.53 | +0.72 | +2.8% | $25.96 | $26.80 | $25.57 | 7,170,800 | |
| $25.81 | +0.60 | +2.4% | $25.22 | $25.85 | $25.11 | 1,871,300 | |
| $25.21 | -0.40 | -1.6% | $25.45 | $25.90 | $24.73 | 1,934,100 | |
| $25.61 | -0.65 | -2.5% | $26.54 | $26.73 | $25.37 | 1,612,600 | |
| $26.26 | -0.18 | -0.7% | $26.38 | $26.56 | $25.83 | 1,142,600 | |
| $26.44 | -0.02 | -0.1% | $26.55 | $26.67 | $25.61 | 1,666,100 | |
| $26.46 | +0.74 | +2.9% | $26.25 | $26.92 | $26.00 | 3,807,810 | |
| $25.72 | -0.11 | -0.4% | $25.75 | $26.09 | $25.30 | 1,536,973 | |
| $25.83 | +0.51 | +2.0% | $25.76 | $26.75 | $25.69 | 2,392,300 | |
| $25.32 | -0.92 | -3.5% | $28.39 | $28.50 | $25.04 | 3,841,100 |
- Ticker
- Dusseldorf:UP0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Nov 11, 2026
Ultragenyx to Participate at Investor Conferences in London
Latest earnings call · Nov 3, 2026
Ultragenyx Pharmaceutical (NASDAQ:RARE) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Apr 30, 2026
Shareholder Meeting (April 2026)
Shareholder meeting · 7 slides
Calls
Replays
Ultragenyx Pharmaceutical (NASDAQ:RARE) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 5:00 PM ET
Watch TranscriptUltragenyx Pharmaceutical (NASDAQ:RARE) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 5:00 PM ET
Watch TranscriptUltragenyx Pharmaceutical (NASDAQ:RARE) Q1 2026 Earnings Call
Tue, May 05, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Ultragenyx to Participate at Investor Conferences in London
Nov 11, 2026
Closed $16.70 (+3.5%) on Nov 11, 2026
Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
Nov 6, 2026
Closed $15.43 (-0.9%) on Nov 6, 2026
Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
Nov 3, 2026
Closed $17.16 (+3.2%) on Nov 4, 2026
Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
Oct 27, 2026
Closed $17.20 (+2.7%) on Oct 28, 2026
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
Oct 14, 2026
Closed $14.90 (-0.1%) on Oct 14, 2026
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
Oct 7, 2026
Closed $14.89 (+3.0%) on Oct 7, 2026
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
Oct 2, 2026
Closed $15.22 (+3.2%) on Oct 2, 2026
Ultragenyx Announces Approval of FAYUVI Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A
Sep 18, 2026
Closed $14.51 (+0.1%) on Sep 18, 2026
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
Sep 17, 2026
Closed $14.50 (+12.6%) on Sep 17, 2026
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
Sep 2, 2026
Closed $14.85 (-44.0%) on Sep 3, 2026
Decks
Shareholder Meeting (April 2026)
Shareholder meeting · 7 slides · Apr 30, 2026
Q4 2025 Earnings Presentation
Earnings · 46 slides · Feb 12, 2026
Q2 2025 Earnings Presentation
Earnings · 42 slides · Aug 5, 2025
Technical Presentation (October 2023)
Technical · 22 slides · Oct 16, 2023
Ultragenyx Pharmaceutical Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 36 in the last 12 months · 222 in all · newest Nov 11, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 3, 2026
- Decks
- 10 decks · latest Apr 30, 2026
Where Ultragenyx Pharmaceutical Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RARE · Home listing | NASDAQ | United States | USD |
| LSE:0LIF | LSE | United Kingdom | USD |
| gettex:UP0 | gettex | Germany | EUR |
| BMV:RARE | BMV | Mexico | MXN |
| LS Exchange:A1XCY0 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1XCY0 | Lang & Schwarz | Germany | EUR |
| B3:R2AR34 | B3 | Brazil | BRL |
| BIVA:RARE | BIVA | Mexico | MXN |
| Frankfurt:UP0 | Frankfurt | Germany | EUR |
| Tradegate:UP0 | Tradegate | Germany | EUR |
| BOATS:RARE | BOATS | United States | USD |
| BX Swiss:UP0 | BX Swiss | Switzerland | CHF |
| Dusseldorf:UP0 · This page | Dusseldorf | Germany | EUR |
| Hamburg:UP0 | Hamburg | Germany | EUR |
| Stuttgart:UP0 | Stuttgart | Germany | EUR |
| Hanover:UP0 | Hanover | Germany | EUR |
| Xetra:UP0 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Ultragenyx Pharmaceutical Inc.